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Abstract
Western blot analysis is a commonly employed technique for detecting and quantifying protein levels. However, for small tissue samples, this
analysis method may not be sufficiently sensitive to detect a protein of interest. To overcome these difficulties, we examined protocols for
obtaining protein from adult human cardiac valves and modified these protocols for the developing early embryonic mouse counterparts. In
brief, the mouse embryonic aortic valve regions, including the aortic valve and surrounding aortic wall, are collected in the minimal possible
volume of a Tris-based lysis buffer with protease inhibitors. If required based on the breeding strategy, embryos are genotyped prior to pooling
four embryonic aortic valve regions for homogenization. After homogenization, an SDS-based sample buffer is used to denature the sample
for running on an SDS-PAGE gel and subsequent western blot analysis. Although the protein concentration remains too low to quantify
using spectrophotometric protein quantification assays and have sample remaining for subsequent analyses, this technique can be used to
successfully detect and semi-quantify phosphorylated proteins via western blot from pooled samples of four embryonic day 13.5 mouse aortic
valve regions, each of which yields approximately 1 μg of protein. This technique will be of benefit for studying cell signaling pathway activation
and protein expression levels during early embryonic mouse valve development.
Video Link
The video component of this article can be found at http://www.jove.com/video/51911/
Introduction
Being able to identify and quantify protein expression levels is a standard technique for animal- and cell-based experiments. However, despite a
long-standing interest in early embryonic cardiac valve development, evaluating protein expression in this specific tissue during development is
currently limited to immunohistochemistry in both the chick and mouse1,2. Part of the difficulty of quantifying protein expression in the developing
valves of most model organisms (e.g., chick and mouse) is the small size of the valves, which limits the quantity of protein that can be obtained.
Thus, for quantitative analyses, researchers typically rely on RNA extraction and amplification for subsequent quantitative PCR or microarray
analysis2-5. However, RNA and protein expression levels are not wholly correlative6, so focusing on RNA expression cannot provide a rigorous
account of the numerous changes that occur in any given signaling pathway at various times during developments. Based on this limit in the
currently available methodology, the goal of this procedure was to develop a protocol for reliably obtaining sufficient amounts of protein from
the developing embryonic mouse cardiac valve regions for quantitative analysis of changes that occur in various signaling pathways that are
important in the maturation of this tissue.
Embryonic valves are already commonly dissected from mice for RNA isolation and subsequent gene expression analysis2-5. However, these
studies have been limited to using gene expression as a read-out of signaling pathway activation, which does not allow the detection of detect
post-translational protein modifications that may affect downstream signaling. Using the RNA isolation techniques as a starting point, we began
with dissecting the regions of interest. Because our interest was detecting phosphorylated proteins that were indicative of signaling pathway
activity during a specific period of aortic valve development (E13.5-14.5), we performed all dissections in phosphate-free Tris buffer and collected
the valves in a Tris-based lysis buffer with phosphatase and protease inhibitors. In our specific case, only the aortic valve regions were collected,
but the pulmonary valve region could easily be obtained at the same time. The valve regions were then homogenized and combined with a
sample buffer that is currently used to study protein expression in adult cardiac valves7. By using small sample volumes (e.g., 2 μl) and pooling
valve regions from embryos with the same genotype, we were able to detect phosphorylated and nonphosphorylated proteins at embryonic day
13.5 8. Because the valve regions can be frozen and stored in lysis buffer, embryos can be genotyped if needed before pooling.
This technique broadens the set of tools that are available for evaluating cell signaling pathways during development and provides a
quantitative compliment to immunohistochemistry, specifically for the developing cardiac valves. This technique should be of benefit not only to
developmental cardiologists but also to all developmental biologists who work with early stage embryos are interested in regions that contain
limited tissue.
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Protocol
NOTE: All experiments were approved by the Institutional Animal Care and Use Committee at the University of North Carolina at Chapel Hill.
1. Excise the Aortic Valve
1. Using an approved euthanasia technique for the embryonic stage of interest, euthanize a pregnant mouse with pups at the desired embryonic
day (E) of development.
2. Use 70% ethanol to sterilize the abdomen of the pregnant female. Lift the skin and muscle of the lower abdomen up and away from the
internal organs, and dissect open the female’s lower abdominal cavity to allow access to the uterine horn.
3. To retrieve the uterine horn, hold the cervix with forceps and carefully cut caudal to the forceps. Lift the uterine horn, cutting any connective
tissue that keeps the horn in place, and complete the removal by cutting the junction of the uterine horn with the oviduct.
4. Place the dissected uterine horn in a Petri dish containing cold 0.1 M Tris buffer (pH 7.6) and rinse as needed. Then, cut the uterine horn
open length-wise to expose the embryonic sacs.
5. To expose the embryo, cut open an embryonic sac at the junction of the placenta and the embryo and cut the umbilical vessels to free
the embryo. Place the dissected embryo in a second Petri dish with cold 0.1 M Tris buffer. Return the first Petri dish with the remaining
undissected embryos to ice until ready for the next embryo.
6. To improve chest wall access within the embryo, decapitate the embryo. If genotyping is necessary, remove and save an extra tissue piece in
an Eppendorf tube placed on ice.
7. Place the embryo on its back, and cut the chest wall vertically along the side of the rib cage, near a forelimb, and horizontally above the
diaphragm to visualize the heart. Then, open the chest wall to expose the heart.
8. Using forceps to hold high along the great vessels, lift the heart using forceps and cut the vessels below. Then, cut above the forceps to free
the heart. If the pulmonary vessels remain uncut, the lungs may be removed with the heart and should be removed before continuing.
9. Cut and remove the pulmonary artery above the level of the valve; at the embryonic stages described herein, the pulmonary artery is slightly
opaque, which aids in its discrimination from the valve region. Cut just below the pulmonary valve, avoiding the trabeculated ventricular
myocardium and collect as described in step 1.10 if this region is also of interest. Here and in the next step, use capillary action to draw
excess Tris buffer away from the region of interest prior to collecting in lysis buffer.
10. Carefully remove the aorta distal to the aortic valve, just above the level of the valve; like the pulmonary artery, the aorta remains slightly
opaque at these embryonic stages, aiding in its removal. Cut just below the aortic valve, again avoiding the trabeculated ventricular
myocardium, and transfer the valve using forceps to an Eppendorf tube with 2 μl lysis buffer (described in the Materials table) containing
protease and phosphatase inhibitors on ice.
11. Repeat steps 1.6-1.10 until the valves have been excised from all embryos, collecting each valve in a separate Eppendorf tube. If all embryos
have the same genotype, all valves may be collected in a single Eppendorf tube.
12. If genotyping is to be performed to determine which valves to pool together, immediately place samples in lysis buffer at -80 °C until further
use. Samples can then be pooled after genotyping (step 2.1.1).
2. Protein Extraction
1. Thaw collected tissues on ice and centrifuge at 13,100 x g for 1 min to collect the tissues in lysis buffer at the bottom of the tube.
1. If embryos were genotyped, use a pipette to gently collect and pool lysis buffer containing the valve regions from embryos with similar
genotypes. To ensure a strong band, pooling 3-4 valve regions from E13.5 embryos per sample is recommended.
2. If all embryos were of the same genotype and all valve regions were collected together in Step 1.10, lyse the entire sample, as
described in Step 2.2.
2. Check the volume of the resulting pooled sample and add lysis buffer to a total volume of 40 μl; then, disrupt and homogenize samples using
5 mm stainless steel beads in Eppendorf tubes. Operate the lyser for 2-4 min at 50 Hz, as per the manufacturer’s instructions. Spin tubes
briefly, (~13,100 x g for 1 min), and transfer samples to new tubes, leaving behind the insoluble debris.
3. Prepare and separate samples for SDS-PAGE and transfer for subsequent western blot analysis, following a protocol such as Eslami et al9.
Blotting for a loading control protein is essential for protein quantification.
Representative Results
Using this preparation technique, we were able to detect phosphorylated Smad1,5,8 (pSmad) in single aortic valve regions from E13.5 embryos.
As shown in Figure 1A, the protein isolated from even a single valve region is sufficient to detect a faint pSmad band. Signal intensity increases
proportionately to the number of valve regions that are pooled. Importantly, the pSmad/β-actin ratio remains nearly constant across the different
sample sizes (Figure 1C). Due to the low levels of protein available, the same blot cannot be stripped and reprobed for total Smad. However, a
separate blot showing total Smad 1 and β-actin shows the same expression pattern (Figure 1B).
These valve regions are almost entirely devoid of contaminating ventricular myocardium. Using this preparation technique in combination with
samples of the right ventricle, we were unable to detect ventricular myocardium marker ANP in aortic valve regions, whereas this marker was
readily detected in the ventricle (Figure 2). Further, the ventricular myocardial marker myosin light chain 2V is also readily detected in the
ventricular sample but is barely detectable in the aortic valve regions. These results support the preciseness of the dissection.
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Figure 1. Smad phosphorylation in embryonic aortic valve regions. Samples were prepared with increasing numbers of pooled embryonic
mouse aortic valve regions, ranging from 1 to 4 valve regions per sample. Each sample includes all proteins isolated from the entire valve
region(s) in a total volume of 25-28 μl. Prepared tissues were then subjected to western blot analysis for phosphorylated Smad1,5,8 (pSmad)
(A), total Smad1 (C), and β-actin (A, C). Protein was detected using Lumigen ECL Ultra and imaged with UVM VisionWorks software. The band
intensity of pSmad and β-actin is proportional to the amount of starting material, as quantified in (B) using ImageJ software. The data presented
are the mean and standard deviation of two separate blots.Please click here to view a larger version of this figure.
 
Figure 2. Aortic valve regions do not express ventricular myocardium markers. Samples were prepared with increasing numbers of pooled
embryonic mouse aortic valve regions, ranging from 1 to 4 valve regions per sample, or with a sample of the right ventricle. Samples were
processed as described in Figure 1 and blotted for the ventricular myocardium markers ANP (A) and myosin light chain (MLC)-2v (B). ANP is
completely restricted to the ventricular sample, and MLC-2v is expressed at extremely low levels compared with the ventricular sample. β-actin is
shown as a loading control.
Discussion
The ability to quantify protein levels in early embryonic mouse and chick cardiac valve regions provides an additional tool for understanding
the critical cellular signaling events for valve development. Our protocol described herein does not differ greatly from standard protein isolation
procedures. However, by modifying some key steps, we have successfully obtained phosphorylated proteins from extremely small sample
sizes. To achieve this outcome, the following steps are of particular importance. To ensure that quality protein is obtained, it is crucial to keep
samples chilled, whether on ice or by using ice-cold buffers, in the presence of protease and, if necessary, phosphatase inhibitors. Further,
homogenization with a device that is designed to process small sample volumes is essential for adequately disrupting cell membranes. Even
with these precautions, the obtained yield of protein may be too low to detect via the Bradford assay with a spectrophotometer or a protein
quantification kit and still have sample available for subsequent analyses. We were able to determine that each aortic valve region contains
approximately 1 μg of protein by pooling 7 aortic valve regions and using the entire sample for quantification. Despite this limitation, sufficient
protein is obtained to detect phosphorylated and non-phosphorylated proteins, though the lack of prior quantification makes a loading control
essential. We specifically utilized β-actin because it is a high abundance protein, which allowed us to detect it even after stripping the membrane
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numerous times; its molecular weight differed from our proteins of interest; and it is ubiquitously expressed. A trial western blot with different
numbers of pooled samples is recommended to determine how many tissues must be pooled for either embryonic cardiac valve regions at other
stages of development or for other small tissues of interest. In addition, we recommend pooling at least three tissue samples for each protein
sample to account for variability in the size of the dissected tissues as well as in the length of time each embryo sat on ice prior to dissection. If
the protein of interest cannot be detected via western blot even after pooling samples, we recommend reducing sample volume and increasing
the homogenization time to ensure that all potential protein is available for detection. Additionally, protease inhibitors may also be added to
ice-cold Tris buffer during dissections for unstable or easily degraded proteins. If the protein of interest is expressed at low levels, additional
troubleshooting during the western blot portion of the experiment, such as adjusting the primary antibody incubation or the substrate detection
method, may help with visualization.
If the evidence (e.g., immunohistochemistry or in situ hybridization) suggests that a protein of interest is expressed both in the cardiac valves
and the surrounding myocardium, the aortic or pulmonary artery myocardium can be teased apart gently with tungsten needles, even from
valves from E12.5 embryos5. Because this additional step will lengthen the time of dissection and add significant technical difficulty, we suggest
employing it as needed only. In our original study, we began with an immunohistochemical analysis that showed that Smad phosphorylation
was only changed in the valve mesenchyme; thus, we were confident that any differences observed via western blot were due to changes
in expression in the valve mesenchyme8. Further, because the developing outflow tract valves sit at the junction of the great arteries and the
ventricles, performing a control blot for ventricular contamination using a ventricular myocardium-specific antibody such as ANP or MLC-2v is
recommended.
Because the valves undergo dramatic reorganization during their development, we offer the following stage-specific recommendations for
the cushions/valves and their surrounding tissue. For the early cushions (E9.5-11.5), both the outflow tract and atrioventricular cushions are
easily visualized and dissected due to the translucency of the myocardium10; however, these embryos are small, and dissecting needles are
recommended instead of forceps and microscissors. For mid-stage differentiation (E12.5-14.5)10, the semilunar valves (i.e., the aortic and
pulmonary artery valves) will be more readily accessible than the atrioventricular valves (i.e., the mitral and tricuspid valves). However, the
semilunar valves must be carefully dissected because the aorta and pulmonary artery are septating and rotating during this time frame11,12.
Careful attention should be given to the rotation of the base of the aorta and pulmonary artery, and the midpoint between these arteries should
be consistently identified. At later stages of valve maturation and condensation (E15.5 and later)10, the mitral and tricuspid valves can be teased
away from inside the ventricles; however, the semilunar valves should be more easily accessible.
Western blot analysis is a long-standing technique for quantifying protein expression levels in adult cardiac valves13, where the biopsy size is
large. In contrast, the complimentary early embryonic analyses have focused on either non-quantitative immunohistochemistry to detect protein
expression or reverse transcription PCR, where the small starting amount of isolated mRNA can be amplified prior to analysis. These currently
employed techniques provide some pertinent information regarding changes in signaling and gene expression but lack the ability to quantitatively
assess protein levels. With this protocol, we can now add quantitative protein expression data to correlate with the quantitative mRNA expression
data and immunohistochemical analyses.
This protocol compliments established techniques for isolating mRNA from the embryonic cardiac valves and imaging protein expression. As
such, combining these techniques will allow for more complete analyses of the up- and down-regulation of signaling pathways, from mRNA to
post-translational protein modification. Further, this technique allows for quantification of protein expression, which will enhance currently utilized
immunohistochemistry techniques. Together, we believe that this technique will be of interest for any researcher interested in the cardiac valves
or preparing other particularly small tissue explants for quantitative western blot analysis.
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